As a new-type foreign trade service provider driven by both technological transformation and foreign trade business, HiSiaddi has established a "1+2+3+4=1" service system and can supply bronopol sourced from multiple well-known original manufacturers. Endowed with R&D capabilities, HiSiaddi has repeatedly resolved customized bronopol product demands for clients by leveraging technological transformation cooperation with factories and accurate market insight. The following is a case of customized bronopol solutions delivered by HiSiaddi.
Should you require further customized service solutions, please contact HiSiaddi customer service.
Headquartered in Paris, France, Cosmepure has 27 years of experience in R&D and production of European salon skincare products, medical wound care stock solutions and premium maternal & infant care products. It supplies raw materials to French Auchan cosmetic chains, multiple European dermatology hospitals and Swiss infant skincare brands. All its products strictly comply with EU CosIng cosmetic raw material specifications, French AFNOR standards, REACH and FDA cosmetic access criteria. As a typical mid-to-high-end raw material purchaser, it does not compete on low prices, features fixed formulas with raw material indicators bound to drug regulatory filings, and conducts full traceability and testing for each batch of raw materials. Its total annual demand for bronopol (Bronopol, CAS: 52-51-7) stands at 96 tons, split into 42 tons of medical wound antiseptic grade, 35 tons of salon essence antiseptic grade and 19 tons of customized infant & child care special grade. It previously purchased refined bronopol from BASF Germany on a long-term basis. Driven by surging local European chemical raw material prices and extended production lead times of up to 110 days at overseas major manufacturers, the client launched a localized Chinese raw material customization procurement project.
The client independently contacted 3 conventional domestic bronopol manufacturers in the early stage, yet these suppliers could only provide standard industrial-grade and ordinary cosmetic-grade bronopol available off the shelf, failing to fulfill the client’s three core customized requirements and stalling procurement. The core customized demands conflict with standard off-the-shelf products as follows:
1. Purity and impurity customization: National standard bronopol is qualified with a main content of ≥99.0%, while the client requires HPLC main content of 99.5%±0.2%, inorganic bromide impurity ≤120ppm, free nitro by-products <50ppm, and single heavy metal (lead, arsenic, mercury, cadmium) content <0.5ppm. Conventional processes generate excessive by-products, and standard mass production lines cannot precisely control impurity levels.
2. Particle size and dissolution customization: The infant & child care formula adopts a low-temperature weakly acidic water-based system, requiring customized ultra-fine crystalline powder with 325-mesh passing rate ≥99.8% and complete dissolution in pure water within 10 seconds at room temperature without suspended agglomerates. Standard commercial products mostly consist of coarse crystalline particles with slow dissolution; trace undissolved residues easily cause flocculent precipitation in essence liquids. Medical-grade bronopol requires large crystalline particles (16–30 mesh) to reduce moisture absorption and caking during storage. Domestic manufacturers only produce unified crushed specifications and cannot conduct differentiated production by particle size.
3. Split packaging and internal control customization: The client’s European workshop adopts automatic feeding and rejects standard 25kg kraft fiber drums. It requires independent small-specification packaging of 5kg with food-grade PE drums lined with aluminum foil vacuum layers, each drum attached with a unique production traceability code and bilingual quality inspection certificate. Domestic manufacturers only conduct mass bulk packaging without customized split packaging production lines. Additionally, the client customized a narrow pH control range of 5.2–5.8 (versus the national standard general range of 5.0–7.0), which significantly raises production difficulty due to stringent pH regulation.
Multiple domestic manufacturers stated that retrofitting mass production lines would incur high costs and small-batch customized trial production would be uneconomical, so they only offered standard off-the-shelf products and could not meet customized indicators. The client suspended direct procurement and fully entrusted HiSiaddi to coordinate the full process of customized raw material development, pilot sample testing and mass production launch.
HiSiaddi set up a fine chemical raw material technical team and collaborated with 2 high-tech chemical factories holding medical-grade bronopol refining qualifications in China. It split the customized renovation work into four segments: impurity purification, crystal granulation, split packaging process and central control indicators, and implemented the project in three phases: small trial, pilot test and mass production.
1. Customized raw material sourcing: Abandon industrial-grade stearyl alcohol and industrial bromine, and adopt medical-grade starting materials to strictly control heavy metals and inorganic impurities from upstream raw material intake. Optimize temperature control curves for nitrification and bromination synthesis, and implement segmented gradient cooling crystallization to separate inorganic salt by-products, resolving the issue of excessive bromide and nitro by-products.
2. Refining process upgrade: Add two additional anhydrous ethanol recrystallization purification steps to replace the conventional single water washing purification process. Third-party TÜV laboratory testing confirmed that the finished product’s main content stably ranges from 99.45% to 99.62%, bromide content is 102ppm, and all heavy metals are below 0.4ppm, fully meeting the French cosmetic raw material access limits.
· Ultra-fine powder variant for infant & child care: Customize a low-temperature vacuum airflow crushing production line. After crystallization, materials undergo low-temperature drying followed by ultra-fine airflow milling, with screening control to limit 325-mesh residue ≤0.2%. Test results show instant complete dissolution in pure water at 23°C without undissolved residues, compatible with low-temperature skincare stock solution formulas.
· Large particle variant for medical wound care: Adjust the cooling rate during crystallization to form regular crystals through slow natural crystallization, with screening locked at uniform 16–30 mesh particles. The regular particles feature a small specific surface area, with moisture absorption rate <0.3% after 6 months of warehousing, solving the problem of moisture-induced caking of medical raw materials during long-term storage. The two specifications are produced on separate production lines and stored in isolated areas to avoid cross-contamination.
Install real-time online pH monitoring devices in customized workshops to precisely adjust feeding ratios during neutralization and eliminate conventional wide-range neutralization processes. The 1% aqueous solution of finished products stably maintains a pH of 5.3–5.7, falling within the client’s customized range of 5.2–5.8, avoiding formula stratification and unstable bacteriostatic efficiency of end skincare products caused by pH fluctuations of raw materials.
Coordinate the factory to allocate an independent clean split packaging workshop and install additional vacuum sealing equipment: the inner layer adopts food-grade aluminum foil for vacuum sealing to isolate water vapor, covered by an outer sealed PE drum with a net weight accuracy of ±10g per drum. Each drum is affixed with a unique traceability QR code, which can be scanned to view raw material incoming certificates, production batches and full-item test reports. French-English bilingual COA quality inspection certificates are provided to match the client’s European warehousing, automatic feeding and drug regulatory filing requirements.
1. Small trial sample delivery: HiSiaddi shipped three batches of customized samples of three specifications (medical large-particle grade, salon ultra-fine powder grade, customized ultra-fine refined powder for infant & child care) by air to Paris, France. The client’s laboratory conducted continuous 45-day formula compatibility tests:
o When the medical wound antiseptic raw material was added to wound care stock solutions, no impurity precipitation occurred and bacteriostatic rates met European Pharmacopoeia bacteriostatic standards;
o The infant & child care formula exhibited no caking or flocculation under low-temperature stirring, and finished products passed French infant cosmetic safety sampling inspection;
o Salon essence liquids showed no mildew or discoloration after constant-temperature storage for 3 months, with bacteriostatic performance equivalent to original BASF bronopol.
2. Batch trial order delivery: The first customized batch of 12 tons was shipped in three separate specifications, with all customized packaging smoothly clearing customs upon arrival. The client’s full-scale production line operated without any abnormalities after receiving the goods.
3. Signing of annual long-term agreement: Cosmepure formally signed an annual customized bronopol procurement contract of 96 tons with HiSiaddi (42 tons medical grade, 35 tons salon grade, 19 tons infant & child care grade), with scheduled customized production divided into 8 monthly batches. HiSiaddi uniformly manages customized production scheduling at factories, full pre-shipment inspections, export customs declaration and compliance document sorting. The client’s overall procurement cost decreased by 31.5% compared with original German imports, and lead times were shortened from 110 days to 32 days. All subsequent bronopol fine-tuning customization for the client’s new product formula iterations are fully entrusted to HiSiaddi for implementation.
Most domestic bronopol manufacturers focus on mass production of industrial anti-corrosion and ordinary daily chemical standard grades, with production lines designed around general national standard indicators. Retrofitting refining, particle size separation and customized packaging requires additional equipment and labor investment, making small-batch customized trial production unprofitable from an economic perspective, so manufacturers prefer selling standard off-the-shelf products. Low-end purchasers mostly buy bulk industrial bronopol for water treatment and low-cost daily chemicals with loose requirements for purity, particle size and packaging, which can be satisfied with off-the-shelf products. However, mid-to-high-end European and American cosmetic manufacturers are constrained by cosmetic regulations of various countries, with raw material customized indicators bound to end product filings, making standard off-the-shelf raw materials unacceptable.
Unlike low-price-focused purchasers, mid-to-high-end European cosmetic clients prioritize precise and controllable indicators, stable formula compatibility, packaging compatible with automatic production, and complete compliant traceability documents. Customization is not merely adjusting product parameters, but fully tailoring the entire chain from raw material selection, synthetic processes and post-treatment to split packaging to match downstream production systems.
Relying on domestic fine chemical supply chain resources, HiSiaddi breaks the technical barriers between overseas customized demands and factory technical renovations. It acts as a technical implementation service provider for clients, translating end-formula parameters of clients into implementable production process standards for factories, resolving the two-way dilemma of manufacturers’ reluctance to customize and clients’ difficulty in sourcing customized raw materials. It locks in high-quality overseas mid-to-high-end clients through in-depth customized services.
Should you require further customized service solutions, please contact HiSiaddi customer service.